drugset / Trial / NCT02492230
Left Atrial Appendage Closure Compared to Standard Antiplatelet Therapy in Patients With AF Who Underwent PCI
Phase 2
Unknown
50 enrolled
Meshalkin Research Institute of Pathology of Circulation
Boston Scientific Corporation · collab
RandomizedParallel-groupOpen-labelPrevention
Summary
The objective of Left atrial appendage closure compared to standard antiplatelet therapy in patients with AF who underwent percutaneous coronary intervention (LLA-PCI) study is to evaluate the safety and efficacy of implantation of left atrial appendage closure compared to standard antiplatelet therapy for prevention of thromboembolic events and stent thrombosis in subjects with AF who underwent PCI.
Timeline
- Start
- 2015-05
- Primary completion
- 2016-03
- Completion
- 2017-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Warfarin | Small molecule | — | — |